nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—saliva—pharynx cancer	0.0684	0.181	CbGeAlD
Vemurafenib—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0341	0.0549	CbGpPWpGaD
Vemurafenib—RAF1—neck—pharynx cancer	0.032	0.0846	CbGeAlD
Vemurafenib—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0299	0.0482	CbGpPWpGaD
Vemurafenib—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0289	0.0465	CbGpPWpGaD
Vemurafenib—RAF1—parotid gland—pharynx cancer	0.0261	0.0689	CbGeAlD
Vemurafenib—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0254	0.0408	CbGpPWpGaD
Vemurafenib—RAF1—saliva-secreting gland—pharynx cancer	0.025	0.066	CbGeAlD
Vemurafenib—RAF1—brainstem—pharynx cancer	0.0245	0.0646	CbGeAlD
Vemurafenib—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0223	0.0359	CbGpPWpGaD
Vemurafenib—RAF1—epithelium—pharynx cancer	0.0218	0.0576	CbGeAlD
Vemurafenib—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0196	0.0315	CbGpPWpGaD
Vemurafenib—RAF1—trachea—pharynx cancer	0.0193	0.0509	CbGeAlD
Vemurafenib—RAF1—lymphoid tissue—pharynx cancer	0.0168	0.0443	CbGeAlD
Vemurafenib—BRAF—Bladder Cancer—CDH1—pharynx cancer	0.0167	0.0269	CbGpPWpGaD
Vemurafenib—RAF1—spinal cord—pharynx cancer	0.0152	0.0402	CbGeAlD
Vemurafenib—BRAF—lymph node—pharynx cancer	0.0142	0.0375	CbGeAlD
Vemurafenib—RAF1—head—pharynx cancer	0.0135	0.0357	CbGeAlD
Vemurafenib—ABCC1—parotid gland—pharynx cancer	0.013	0.0344	CbGeAlD
Vemurafenib—BRAF—Bladder Cancer—CCND1—pharynx cancer	0.0125	0.0201	CbGpPWpGaD
Vemurafenib—BRAF—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.0121	0.0194	CbGpPWpGaD
Vemurafenib—RAF1—BCR signaling pathway—CD79A—pharynx cancer	0.0112	0.0181	CbGpPWpGaD
Vemurafenib—ABCG2—parotid gland—pharynx cancer	0.0108	0.0285	CbGeAlD
Vemurafenib—ORM1—spinal cord—pharynx cancer	0.0105	0.0278	CbGeAlD
Vemurafenib—ABCG2—saliva-secreting gland—pharynx cancer	0.0103	0.0273	CbGeAlD
Vemurafenib—BRAF—Bladder Cancer—EGFR—pharynx cancer	0.00979	0.0157	CbGpPWpGaD
Vemurafenib—ABCC1—trachea—pharynx cancer	0.00963	0.0254	CbGeAlD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00962	0.0155	CbGpPWpGaD
Vemurafenib—RAF1—lymph node—pharynx cancer	0.00947	0.025	CbGeAlD
Vemurafenib—RAF1—GRB2 events in EGFR signaling—EGFR—pharynx cancer	0.00925	0.0149	CbGpPWpGaD
Vemurafenib—RAF1—SHC1 events in EGFR signaling—EGFR—pharynx cancer	0.00891	0.0143	CbGpPWpGaD
Vemurafenib—BRAF—CDC42 signaling events—CDH1—pharynx cancer	0.00872	0.014	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00843	0.0136	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00834	0.0134	CbGpPWpGaD
Vemurafenib—BRAF—Bladder Cancer—TP53—pharynx cancer	0.00822	0.0132	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00818	0.0132	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00815	0.0131	CbGpPWpGaD
Vemurafenib—RAF1—Nanoparticle-mediated activation of receptor signaling—EGFR—pharynx cancer	0.00735	0.0118	CbGpPWpGaD
Vemurafenib—BRAF—Signaling events mediated by focal adhesion kinase—CCND1—pharynx cancer	0.00726	0.0117	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00714	0.0115	CbGpPWpGaD
Vemurafenib—RAF1—GRB2 events in ERBB2 signaling—EGFR—pharynx cancer	0.00695	0.0112	CbGpPWpGaD
Vemurafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—EGFR—pharynx cancer	0.00695	0.0112	CbGpPWpGaD
Vemurafenib—CYP2D6—brainstem—pharynx cancer	0.00694	0.0183	CbGeAlD
Vemurafenib—RAF1—SHC1 events in ERBB2 signaling—EGFR—pharynx cancer	0.0066	0.0106	CbGpPWpGaD
Vemurafenib—ORM1—lymph node—pharynx cancer	0.00654	0.0173	CbGeAlD
Vemurafenib—ABCG2—spinal cord—pharynx cancer	0.00629	0.0166	CbGeAlD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00629	0.0101	CbGpPWpGaD
Vemurafenib—RAF1—CDC42 signaling events—CDH1—pharynx cancer	0.00603	0.00971	CbGpPWpGaD
Vemurafenib—RAF1—Internalization of ErbB1—EGFR—pharynx cancer	0.00575	0.00926	CbGpPWpGaD
Vemurafenib—ALB—lymph node—pharynx cancer	0.00573	0.0151	CbGeAlD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00573	0.00922	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00565	0.00909	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00551	0.00887	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDH1—pharynx cancer	0.00542	0.00873	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00511	0.00822	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by focal adhesion kinase—CCND1—pharynx cancer	0.00502	0.00808	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00494	0.00795	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00478	0.0077	CbGpPWpGaD
Vemurafenib—ABCC1—lymph node—pharynx cancer	0.00473	0.0125	CbGeAlD
Vemurafenib—ABCG2—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00472	0.00759	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00472	0.00759	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—CCND1—pharynx cancer	0.00472	0.00759	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00449	0.00723	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00448	0.00721	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00433	0.00696	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—CCND1—pharynx cancer	0.00426	0.00685	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—EGFR—pharynx cancer	0.0041	0.0066	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00396	0.00638	CbGpPWpGaD
Vemurafenib—ABCG2—lymph node—pharynx cancer	0.00392	0.0103	CbGeAlD
Vemurafenib—CYP2D6—head—pharynx cancer	0.00383	0.0101	CbGeAlD
Vemurafenib—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00379	0.0061	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—CCND1—pharynx cancer	0.00378	0.00608	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00377	0.00607	CbGpPWpGaD
Vemurafenib—RAF1—AGE/RAGE pathway—EGFR—pharynx cancer	0.0037	0.00595	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00369	0.00594	CbGpPWpGaD
Vemurafenib—BRAF—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00369	0.00593	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00352	0.00566	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00334	0.00537	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00314	0.00506	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00311	0.005	CbGpPWpGaD
Vemurafenib—BRAF—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.0031	0.00498	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00293	0.00471	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—CCND1—pharynx cancer	0.00292	0.00471	CbGpPWpGaD
Vemurafenib—BRAF—Disease—B4GALT5—pharynx cancer	0.00284	0.00457	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00279	0.00448	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00276	0.00444	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.00271	0.00436	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00261	0.0042	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—EGFR—pharynx cancer	0.00261	0.00419	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.00261	0.00419	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00255	0.00411	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00253	0.00407	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—pharynx cancer	0.00249	0.00401	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00243	0.00391	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00232	0.00373	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—EGFR—pharynx cancer	0.00229	0.00369	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CNDP2—pharynx cancer	0.00215	0.00347	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00215	0.00346	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.00214	0.00345	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TP53—pharynx cancer	0.00213	0.00342	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—CCND1—pharynx cancer	0.00202	0.00326	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00202	0.00324	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00202	0.00324	CbGpPWpGaD
Vemurafenib—RAF1—Disease—B4GALT5—pharynx cancer	0.00197	0.00316	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—B4GALT5—pharynx cancer	0.00195	0.00314	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH7—pharynx cancer	0.00195	0.00313	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00193	0.0031	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00193	0.0031	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD79A—pharynx cancer	0.00192	0.0031	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—EGFR—pharynx cancer	0.0019	0.00305	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.0019	0.00305	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00186	0.00299	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00186	0.00299	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—EGFR—pharynx cancer	0.00181	0.00292	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.0018	0.0029	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—EGFR—pharynx cancer	0.0018	0.0029	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—EGFR—pharynx cancer	0.00179	0.00289	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—EGFR—pharynx cancer	0.00179	0.00287	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—pharynx cancer	0.00178	0.00287	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00175	0.00282	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH7—pharynx cancer	0.00171	0.00276	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADH1B—pharynx cancer	0.00171	0.00275	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00168	0.0027	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00168	0.0027	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—EGFR—pharynx cancer	0.00168	0.0027	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—pharynx cancer	0.00167	0.00269	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—EGFR—pharynx cancer	0.00167	0.00268	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—EGFR—pharynx cancer	0.00165	0.00266	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00165	0.00266	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—EGFR—pharynx cancer	0.00164	0.00264	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—B4GALT5—pharynx cancer	0.00163	0.00263	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—EGFR—pharynx cancer	0.00159	0.00255	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00158	0.00254	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.0015	0.00242	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00149	0.00239	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—pharynx cancer	0.00147	0.00237	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00144	0.00231	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.00144	0.00231	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00133	0.00214	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CNDP2—pharynx cancer	0.00117	0.00188	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD79A—pharynx cancer	0.00117	0.00188	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—EGFR—pharynx cancer	0.00114	0.00184	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDH1—pharynx cancer	0.00107	0.00172	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH7—pharynx cancer	0.00106	0.0017	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—EGFR—pharynx cancer	0.00104	0.00167	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000966	0.00155	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH1B—pharynx cancer	0.000928	0.00149	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—B4GALT5—pharynx cancer	0.000887	0.00143	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000873	0.00141	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000818	0.00132	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000766	0.00123	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00074	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EGFR—pharynx cancer	0.000739	0.00119	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000732	0.00118	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EGFR—pharynx cancer	0.000653	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDH1—pharynx cancer	0.00065	0.00105	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000649	0.00104	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000631	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—EGFR—pharynx cancer	0.000627	0.00101	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.00062	0.000998	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—pharynx cancer	0.000609	0.00098	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000571	0.000919	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EGFR—pharynx cancer	0.000507	0.000816	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000501	0.000806	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000479	0.00077	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCND1—pharynx cancer	0.000453	0.000729	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—pharynx cancer	0.000416	0.00067	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—pharynx cancer	0.00038	0.000612	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—pharynx cancer	0.000355	0.000572	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—pharynx cancer	0.000351	0.000565	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—pharynx cancer	0.000348	0.00056	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—pharynx cancer	0.000328	0.000527	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCND1—pharynx cancer	0.000313	0.000504	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—pharynx cancer	0.000298	0.00048	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—pharynx cancer	0.000246	0.000396	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—pharynx cancer	0.000206	0.000332	CbGpPWpGaD
